On July 13, CITIC Securities (06030.HK) declined 3.3% in regular trading, trading at HKD 26.54/share, with turnover of HKD 169 million. The stock continued its post-earnings slide despite a record-breaking H1 profit announcement.

On the news front, although the company disclosed H1 net profit attributable to shareholders of RMB 23.343 billion — a 70% year-over-year surge marking a historic half-year high — the stock has fallen steadily since the July 10 announcement, exhibiting classic sell-the-news behavior. Compounding the pressure, regulatory penalties on the companys investment banking division have intensified, with multiple sponsor representatives receiving warnings from both the Shanghai and Shenzhen stock exchanges. Notably, investors in the delisted Lanhai Medical filed joint liability lawsuits against CITIC Securities over alleged failures in continuous supervision duties during a private placement project.

Sector-wide weakness added further drag, with CSC down 3.79%, CICC down 2.41%, and CAM CSI300 down 2.22%, reflecting broad brokerage sector retracement.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)